Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

3 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Screening Biopsy GOAL Trial B-cell Lymphoma NCT02499003

- 20/09/21 - 1 modulo, 3 itemgroups, 22 elementi, 1 linguaggio
Itemgroups: Admininstrative data, Bone marrow biopsy, Biopsy Tumor
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Biopsy GOAL Trial B-cell Lymphoma NCT02499003

- 20/09/21 - 1 modulo, 1 ItemGroup, 13 elementi, 1 linguaggio
ItemGroup: Biopsy
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: End of Treatment. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Screening Lymphoma GOAL Trial B-cell Lymphoma NCT02499003 - Screening Lymphoma Trial B-cell Lymphoma NCT02499003

- 02/01/18 - 1 modulo, 3 itemgroups, 24 elementi, 1 linguaggio
Itemgroups: Admininstrative data, Characteristics Lymphoma, B Symptoms
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial